GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hwail Pharm Co Ltd (XKRX:061250) » Definitions » Cyclically Adjusted Price-to-FCF

Hwail Pharm Co (XKRX:061250) Cyclically Adjusted Price-to-FCF : 33.73 (As of Jul. 21, 2025)


View and export this data going back to 2002. Start your Free Trial

What is Hwail Pharm Co Cyclically Adjusted Price-to-FCF?

As of today (2025-07-21), Hwail Pharm Co's current share price is ₩1225.00. Hwail Pharm Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was ₩36.32. Hwail Pharm Co's Cyclically Adjusted Price-to-FCF for today is 33.73.

The historical rank and industry rank for Hwail Pharm Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

XKRX:061250' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 26.3   Med: 79.63   Max: 1467.05
Current: 33.81

During the past years, Hwail Pharm Co's highest Cyclically Adjusted Price-to-FCF was 1467.05. The lowest was 26.30. And the median was 79.63.

XKRX:061250's Cyclically Adjusted Price-to-FCF is ranked worse than
50.62% of 324 companies
in the Drug Manufacturers industry
Industry Median: 33.49 vs XKRX:061250: 33.81

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Hwail Pharm Co's adjusted free cash flow per share data for the three months ended in Mar. 2025 was ₩1.954. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ₩36.32 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Hwail Pharm Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Hwail Pharm Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hwail Pharm Co Cyclically Adjusted Price-to-FCF Chart

Hwail Pharm Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 476.12 86.31 79.50 44.00 39.03

Hwail Pharm Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.21 33.26 98.69 39.03 28.63

Competitive Comparison of Hwail Pharm Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Hwail Pharm Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hwail Pharm Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hwail Pharm Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Hwail Pharm Co's Cyclically Adjusted Price-to-FCF falls into.


;
;

Hwail Pharm Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Hwail Pharm Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=1225.00/36.32
=33.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hwail Pharm Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Hwail Pharm Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=1.954/122.5900*122.5900
=1.954

Current CPI (Mar. 2025) = 122.5900.

Hwail Pharm Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 6.222 100.051 7.624
201509 -213.597 100.111 -261.559
201512 18.711 100.220 22.887
201603 -3.118 100.561 -3.801
201606 117.457 100.791 142.861
201609 89.562 101.461 108.213
201612 22.106 101.561 26.683
201703 36.745 102.851 43.797
201706 -7.753 102.611 -9.263
201709 3.419 103.491 4.050
201712 158.174 102.991 188.275
201803 50.691 104.101 59.694
201806 19.521 104.130 22.982
201809 52.975 105.651 61.469
201812 15.665 104.351 18.403
201903 -66.050 104.491 -77.491
201906 41.732 104.881 48.778
201909 97.858 105.200 114.034
201912 -8.096 105.121 -9.441
202003 -54.605 105.354 -63.538
202006 -34.185 105.112 -39.869
202009 0.441 106.198 0.509
202012 50.229 105.765 58.219
202103 83.147 107.357 94.945
202106 34.972 107.579 39.852
202109 137.369 108.759 154.838
202112 25.210 109.676 28.178
202203 46.136 111.848 50.567
202206 18.962 114.072 20.378
202209 -87.866 114.715 -93.898
202212 -147.010 115.179 -156.469
202303 -59.942 116.507 -63.071
202306 -98.015 117.182 -102.538
202309 81.413 118.964 83.895
202312 154.213 118.837 159.083
202403 -10.191 120.123 -10.400
202406 -128.056 120.007 -130.812
202409 -168.954 120.861 -171.371
202412 -5.376 121.135 -5.441
202503 1.954 122.590 1.954

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hwail Pharm Co  (XKRX:061250) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Hwail Pharm Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Hwail Pharm Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Hwail Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
904-7, Sangsin-Ri, Hyangnam-Eup, Hwaseong, Gyeonggi, KOR, 445-746
Hwail Pharm Co Ltd is engaged in manufacturing and distribution of raw materials used in pharmaceutical production. Its products include antitussive expectorants, spasmolytic, stomach function modifier, anti-inflammatory, and others.

Hwail Pharm Co Headlines

No Headlines